Welcome to our dedicated page for Capstone Holding SEC filings (Ticker: CAPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capstone Holding Corp’s filings can feel like two companies in one—clinical trials for an FDA-designated peptide drug on one page, stone cladding revenue on the next. If you have ever searched for “Capstone Holding Corp SEC filings explained simply” or wondered how to track “Capstone Holding Corp insider trading Form 4 transactions,” you know the challenge. Our platform removes that complexity.
Stock Titan’s AI reads every 10-K, 10-Q, 8-K and proxy so you don’t have to. Need the biotech pipeline risks buried deep in the “Risk Factors” section? Our summaries surface them in plain English. Looking for construction-segment margins in the “MD&A” of a “Capstone Holding Corp quarterly earnings report 10-Q filing”? They’re highlighted and charted. Real-time alerts flag “Capstone Holding Corp Form 4 insider transactions real-time,” letting you monitor executive stock moves minutes after they hit EDGAR. You can also review “Capstone Holding Corp 8-K material events explained” or dive into the “Capstone Holding Corp proxy statement executive compensation” table without scrolling through hundreds of pages.
Whether you’re comparing trial milestones across years, mapping stone sales by region, or seeking a “Capstone Holding Corp annual report 10-K simplified,” our AI-powered analysis delivers. Investors use these tools to spot revenue shifts between segments, evaluate dilution risk linked to drug development, and time decisions based on “Capstone Holding Corp earnings report filing analysis.” Transparent data, expert context, and real-time updates—all in one place.
Capstone Holding (Nasdaq: CAPS) filed an 8-K announcing a first amendment to its May 14 2025 common-stock purchase agreement with Tumim Stone Capital.
- Raises the single VWAP Purchase limit to $3 million (from $2 million)
- Eliminates the 100% five-day average volume restriction; new ceiling is the lesser of 40% same-day volume or $3 million divided by prior-day VWAP
- Aggregate facility size remains up to $20 million; shares still priced at 97% of the lowest three-day VWAP
The amendment provides faster, larger draws for working-capital needs but may accelerate dilution and trading pressure because more shares can be issued below market in a single transaction.
FAQ
What is the current stock price of Capstone Holding (CAPS)?
What is the market cap of Capstone Holding (CAPS)?
What are the primary business segments of Capstone Holding Corp?
What is the focus of Capstone’s biotechnology segment?
How does the construction materials segment operate?
What makes Capstone's approach unique in its biotechnology initiatives?
How does Capstone Holding Corp manage its tax attributes?
What role does TotalStone, LLC play in the company’s structure?
How does Capstone maintain corporate governance?
How does Capstone differentiate itself from competitors?
